Search
Search
Close this search box.

Aurora Cannabis reports $87 million loss, aims for positive free cash flow

Aurora Cannabis reports $87 million loss, aims for positive free cash flow

Aurora Cannabis’ financial woes have continued in the first quarter of 2023, with the Canadian cannabis giant posting increasing net losses despite a slight bump in revenues.

Over the three months to March 31, 2023, Aurora posted a net loss of C$87m and net sales of C$64m, up from a net loss of $67.2m and sales of $61.7m in the previous quarter.

Despite this, the company’s EBITDA profits were positive for the period, coming in at $300k, in what CEO Miguel Martin said was a sign its ‘business transformation plan’ is working.

Mr Martin also suggested the company had now made annual saving of $400m by ‘rationalising expenses’, and would continue to slim its operations by closing its leased facility in Denmark, which it hopes will help it reduce losses by another $40m over the next year.

High Tide Reports Third Consecutive Quarter of Record Revenue and Adjusted EBITDA of $118.1 Million and $6.6 Million, Respectively

Its Canadian stablemate also published financial results today, reporting a growing revenues and profit margins.

Over the three months to April 30, 2023, High Tide reported revenues of C$118.1m, up 46% on revenues of C$81m a year earlier, but remained flat month-on-month.

Net losses also improved, falling from C$8.3m in Q2 2022 to C$1.6m in the same period this year.

Adjusted EBITDA, meanwhile, increased 20% month-on-month to C$6.6m, and more than doubled from C$2.2m in 2022.

“We remain on track towards achieving our communicated goal of generating positive free cash flow by the end of calendar 2023,” Raj Grover, President and Chief Executive Officer of High Tide said.

Americans Say Cannabis Is Safer Than Alcohol And Cigarettes (And Less Addictive Than Technology)

A new survey conducted by the American Psychiatric Association (APA) and Morning Consult revealed last week that Americans think cannabis is much less dangerous than opioids, alcohol and cigarettes.

According to the results of interviews with 2201 adults conducted between April 20 – 22 2023, 38% of respondents said cannabis was ‘very or somewhat unsafe’.

This compared to 84% stating cigarettes were unsafe, 65% believing alcohol was unsafe, and 66% believing prescription opioids were unsafe.

Cannabis was also believed to be less addictive than all other substances listed in the survey, which included the use of technology.

“It is clear that we have gotten the message through that cigarettes are dangerous and addictive,” APA President Petros Levounis said in a press release. 

“We can help prevent more Americans from other potentially addictive behaviors, like drinking alcohol and technology use. For instance, vaping is just as, if not more, addictive than cigarette smoking.”

⏰ Pre-order discount ends Jan 15
-- Days
-- Hours
-- Mins
Data packs delivered January 2026
🔬 New Report Due January 2026

Global Medical Cannabis Market Review 2026

A comprehensive analysis of the international medical cannabis supply chain — examining country-specific data on exports, imports, market size, domestic production, and distribution landscapes. Understand the driving forces behind global supply dynamics, the impact of telemedicine on patient access, and regulatory changes shaping the market.

What's covered

  • 📊 Global supply chain overview — understand export/import dynamics and domestic production capabilities
  • 🌍 8 export country snapshots — Canada, Portugal, Denmark, North Macedonia, Spain, Australia, Czech Republic, South Africa
  • 👥 6 patient market snapshots — Australia, Germany, UK, Poland, Brazil, France
  • 🔮 Key themes — Canada's global impact, telemedicine growth, new market openings, quota changes
Export Markets
🇨🇦 Canada 🇵🇹 Portugal 🇩🇰 Denmark 🇲🇰 N. Macedonia 🇪🇸 Spain 🇦🇺 Australia 🇨🇿 Czechia 🇿🇦 South Africa
Patient Markets
🇦🇺 Australia 🇩🇪 Germany 🇬🇧 UK 🇵🇱 Poland 🇧🇷 Brazil 🇫🇷 France
100% free • No credit card required
As trusted by
DIAGEO KPMG Coca-Cola BARCLAYS BNP PARIBAS AB InBev NOVARTIS Johnson & Johnson PEPSICO AXA POLITICO Bloomberg amazon CNN Business
Part of our annual market review series GDPR compliant

Related Posts

Related Posts

CONNECT

Related Posts

Related Posts

Recent Posts

Related Posts

Subscribe to our mailing list to receives daily updates!

We won’t spam you

Categories

Browse by Tags

CATEGORIES

EDITION

BUSINESS OF CANNABIS

© 2023 Prohibition Holdings Ltd. All Rights Reserved.

EDITION

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?